CNQ:AGN

Algernon Pharmaceuticals Stock Signals

etoro logo Buy AGN
*Your capital is at risk
$0.0450
+0 (+0%)
At Close: Jun 03, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Algernon Pharmaceuticals Inc.

General

Signal Type Signal Value Data
Score 0.000 31 days ( 0 %
Last Price $0.0450 0 %
Performance History
7 Days
$0.0450 $0.0450
0%
30 Days
$0.0450 $0.0450
0%
12 Mos
$0.750 $0.0450
-94.00%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0450 - $0.0450
Trend - 3 mos -70.26 % High Width: 206.50 %
Pred. range - 3 mos N/A - $0.0719 Low -100.00 % - 59.76 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Apr 21, 2026 - 31 days
RSI Short Pivot Signal Buy Very Low Apr 29, 2026 - 25 days
Short MA 3 mos Sell Low Apr 20, 2026 - 32 days
Long MA 3 mos Sell Medium Apr 20, 2026 - 32 days
Short/Long MA 3 mos Sell Medium Apr 21, 2026 - 31 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 28.74
Signal Type Signal Value Importance Data
Trend - 12 mos -53.68 % Very High Width: 1,773.22 %
Pred. range - 12 mos N/A - $0.257 High -100.00 % - 471.70 %
Short MA 12 mos Sell Very High Apr 20, 2026 - 32 days
Long MA 12 mos Sell Very High Apr 20, 2026 - 32 days
Short/Long MA 12 mos Sell Very High Jan 07, 2026 - 103 days
Pivot Long Buy Low Apr 21, 2026 - 31 days
RSI Long Pivot Signal Buy Low May 08, 2026 - 18 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ALGERNON PHARMACEUTICALS INC.
Algernon Pharmaceuticals
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets N...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE